Keisuke Kataoka is an expert in Hematology at National Cancer Centre (Japan). As of October 2026, ScienceLeadR ranks Keisuke Kataoka in the top 1% of experts worldwide for Lymphoma and Lymphoproliferative Disorders, and in the top 1% of experts in Japan for Leukemia. Keisuke Kataoka has authored 367 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,229 (community average: 125). How the SLR is computed.

LeadR Profile

Keisuke Kataoka National Cancer Centre Japan
1 229 ScienceLeadR Reputation 1229
Network Map

Hematology

Subspecialties: Transplantation - Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026

Source: PubMed

National Cancer Centre

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 367

Citations

Citations: 10 377 1st author: 29 Last author: 51 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.
PMID 42864421 — cells, up-regulation, leukemia-lymphoma, adult t-cell, lymphoma, leukemia, leukemia, t-cell, therapeutics, t-lymphocytes, prognosis
EMBO Mol Med20260
Biallelic deficiencies of FDPS are required for skin lesion formation in FDPS-associated porokeratosis.
PMID 42862887 — skin, syphilis, dermatology, porokeratosis
Br J Dermatol20260
Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.
PMID 42685638 — cells, retrospective studies, mesenchymal stem cells, gastrointestinal tract, graft vs host disease, transplants, therapeutics, stromal cells, cell transplantation, steroids, globulins, infections
Cytotherapy20260
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
PMID 42668320 — blood, graft vs host disease, transplants, encephalitis, transplantation, mycophenolic acid
Bone Marrow Transplant20260
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
PMID 42633641 — regression analysis, cells, microscopy, electron, scanning transmission, melphalan, lymphoma, leukemia, stem cells, therapeutics, cell transplantation, stem cell transplantation, transplantation, prognosis
Leuk Lymphoma20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map